C021: Synagis Biosimilar Stable Cell Line (CHO)
The Synagis biosimilar stable cell line alone can be transferred alone or together with the technology of process development and/or antibody purification.
C021P: Palivizumab Biosimilar, RSV Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The monoclonal antibody palivizumab biosimilar specifically binds to an epitope in the A antigenic site of the F protein of RSV (respiratory syncytial virus).
Applications: ELISA, neutralization, functional assays.